IVVD Q2 2024 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$2M96.1% margin

Operating Income

-$49M-2175.2% margin

Net Income

-$47M-2086.9% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$42M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$177M

Total Liabilities

$37M

Stockholders' Equity

$141M

Cash & Equivalents

$148M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$2M	$0	—
Operating Income	-$49M	-$54M	+8.6%
Net Income	-$47M	-$50M	+5.9%

Revenue Segments

Product

$2M100%